Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eterna Therapeutics Inc. - Common Stock
(NQ:
ERNA
)
1.990
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.990
Bid (Size)
1.990 (4)
Ask (Size)
2.900 (1)
Prev. Close
1.990
Today's Range
1.990 - 1.990
52wk Range
0.8401 - 2.990
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q1 2024
May 14, 2024
Eterna Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost
March 15, 2024
Intuitive Surgical stock is on the rise Friday as investors in ISRG shares learn about FDA approval for the company's da Vinci 5.
Via
InvestorPlace
Exposures
Product Safety
Performance
YTD
+5.85%
+5.85%
1 Month
-7.01%
-7.01%
3 Month
+23.60%
+23.60%
6 Month
+101.01%
+101.01%
1 Year
-10.36%
-10.36%
More News
Read More
ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023
March 15, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 04, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 01, 2023
Via
Benzinga
EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
September 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 04, 2023
Via
Benzinga
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeutics
December 20, 2022
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Friday
May 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 07, 2022
Via
Benzinga
What's Going On With Eterna Therapeutics Stock Today?
December 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 06, 2022
Via
Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
October 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 19, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.